Synergistic interaction between HDAC and MCL-1 inhibitors through downregulation of BCL-XL in multiple myeloma
Anja Schneller,
Niklas Zojer,
Arnold Bolomsky,
Heinz Ludwig
Affiliations
Anja Schneller
Department of Medicine I, Wilhelminen Cancer Research Institute, Clinic Ottakring, Vienna, Austria; Recipient of a DOC Fellowship of the Austrian Academy of Sciences at the Wilhelminen Cancer Research Institute
Niklas Zojer
Department of Medicine I, Wilhelminen Cancer Research Institute, Clinic Ottakring, Vienna
Arnold Bolomsky
Department of Medicine I, Wilhelminen Cancer Research Institute, Clinic Ottakring, Vienna
Heinz Ludwig
Department of Medicine I, Wilhelminen Cancer Research Institute, Clinic Ottakring, Vienna
